BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29530844)

  • 1. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species.
    Abastabar M; Al-Hatmi AMS; Vafaei Moghaddam M; de Hoog GS; Haghani I; Aghili SR; Shokohi T; Hedayati MT; Daie Ghazvini R; Kachuei R; Rezaei-Matehkolaei A; Makimura K; Meis JF; Badali H
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
    Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
    Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Rezaei-Matehkolaei A; Khodavaisy S; Alshahni MM; Tamura T; Satoh K; Abastabar M; Shokoohi GR; Ahmadi B; Kord M; Taghipour S; Makimura K; Badali H
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
    Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
    Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.
    Baghi N; Shokohi T; Badali H; Makimura K; Rezaei-Matehkolaei A; Abdollahi M; Didehdar M; Haghani I; Abastabar M
    Med Mycol; 2016 Oct; 54(7):757-63. PubMed ID: 27118804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Shokoohi GR; Badali H; Mirhendi H; Ansari S; Rezaei-Matehkolaei A; Ahmadi B; Vaezi A; Alshahni MM; Makimura K
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
    Maeda J; Nanjoh Y; Koga H; Toga T; Makimura K; Tsuboi R
    Med Mycol J; 2016; 57(1):J1-6. PubMed ID: 26936346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
    Ozdemir HG; Oz Y; Ilkit M; Kiraz N
    Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
    Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
    Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luliconazole, a highly effective imidazole, against Fusarium species complexes.
    Gharaghani M; Hivary S; Taghipour S; Zarei-Mahmoudabadi A
    Med Microbiol Immunol; 2020 Oct; 209(5):603-612. PubMed ID: 32253502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains.
    Abastabar M; Rahimi N; Meis JF; Aslani N; Khodavaisy S; Nabili M; Rezaei-Matehkolaei A; Makimura K; Badali H
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6916-6919. PubMed ID: 27572389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
    Chowdhary A; Hagen F; Curfs-Breuker I; Madrid H; de Hoog GS; Meis JF
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6642-5. PubMed ID: 26239995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activity of luliconazole against nondermatophytic moulds.
    Maeda J; Koga H; Yuasa K; Neki D; Nanjoh Y; Inagaki K; Reangchainam S; Kampirapap K; Makimura K; Harada K; Tsuboi R
    Med Mycol; 2020 Jul; 58(5):703-706. PubMed ID: 31758690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
    J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
    Al-Hatmi AM; Meletiadis J; Curfs-Breuker I; Bonifaz A; Meis JF; De Hoog GS
    J Antimicrob Chemother; 2016 Apr; 71(4):953-5. PubMed ID: 26702918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.